Search details
1.
Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer.
Gynecol Oncol
; 164(3): 645-650, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35031189
2.
Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models: Literature Review, Feasibility Assessment, and Impact Evaluation.
Value Health
; 23(12): 1523-1533, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33248507
3.
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.
Lancet
; 391(10125): 1108-1120, 2018 03 17.
Article
in English
| MEDLINE | ID: mdl-29179954
4.
Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.
BMC Public Health
; 15: 1183, 2015 Nov 26.
Article
in English
| MEDLINE | ID: mdl-26612044
5.
JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value.
J Manag Care Spec Pharm
; 28(1): 108-114, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34949111
6.
Minimum Threshold of Bariatric Surgical Weight Loss for Initial Diabetes Remission.
Diabetes Care
; 45(1): 92-99, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34518376
7.
Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
J Manag Care Spec Pharm
; 27(6): 732-742, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34057391
8.
Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
Pharmacoeconomics
; 37(10): 1287-1300, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31270747
9.
The Impact of Anti-Retroviral Therapy on Tuberculosis Detection at the National Level in South Africa.
Am J Trop Med Hyg
; 99(6): 1407-1414, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30277200
10.
Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis.
CNS Drugs
; 32(12): 1145-1157, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30141001
11.
The Authors Respond: Reframing the Value of Treatments for Relapsed Refractory Multiple Myeloma.
J Manag Care Spec Pharm
; 24(7): 712-713, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29952702
12.
Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
Contraception
; 98(5): 389-395, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29859148
13.
Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States.
J Manag Care Spec Pharm
; 24(1): 29-38, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29290170
14.
The effectiveness and value of tirzepatide for type 2 diabetes mellitus.
J Manag Care Spec Pharm
; 28(6): 680-684, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35621725
15.
The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon.
Soc Sci Med
; 170: 161-169, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27792922
16.
Economic Benefit-Cost Analysis of Select Secondary Prevention Interventions in LMIC.
Glob Heart
; 10(4): 319-21, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26704964
17.
The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis.
Lancet Glob Health
; 3(4): e206-16, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25772692
Results
1 -
17
de 17
1
Next >
>>